Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Bafetinib |
Synonyms | |
Therapy Description |
Bafetinib (NS-187) is a tyrosine kinase inhibitor with activity against Lyn, SRC kinase, DDR1/2, and BCR-ABL, but not the T315I mutation (PMID: 21154127, PMID: 19890374). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Bafetinib | NS-187|INNO-406 | BCR-ABL Inhibitor 31 DDR1 Inhibitor 10 DDR2 inhibitor 7 LYN Inhibitor 3 | Bafetinib (NS-187) is a tyrosine kinase inhibitor with activity against Lyn, SRC kinase, DDR1/2, and BCR-ABL, but not the T315I mutation (PMID: 21154127, PMID: 19890374). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|